JPS4829221B1 - - Google Patents

Info

Publication number
JPS4829221B1
JPS4829221B1 JP46053047A JP5304771A JPS4829221B1 JP S4829221 B1 JPS4829221 B1 JP S4829221B1 JP 46053047 A JP46053047 A JP 46053047A JP 5304771 A JP5304771 A JP 5304771A JP S4829221 B1 JPS4829221 B1 JP S4829221B1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP46053047A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS4829221B1 publication Critical patent/JPS4829221B1/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01R—ELECTRICALLY-CONDUCTIVE CONNECTIONS; STRUCTURAL ASSOCIATIONS OF A PLURALITY OF MUTUALLY-INSULATED ELECTRICAL CONNECTING ELEMENTS; COUPLING DEVICES; CURRENT COLLECTORS
    • H01R33/00—Coupling devices specially adapted for supporting apparatus and having one part acting as a holder providing support and electrical connection via a counterpart which is structurally associated with the apparatus, e.g. lamp holders; Separate parts thereof
JP46053047A 1967-11-17 1971-07-16 Pending JPS4829221B1 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1610167A CH510655A (de) 1967-11-17 1967-11-17 Verfahren zur Herstellung neuer Halogenpregnadiene

Publications (1)

Publication Number Publication Date
JPS4829221B1 true JPS4829221B1 (ja) 1973-09-08

Family

ID=4414467

Family Applications (1)

Application Number Title Priority Date Filing Date
JP46053047A Pending JPS4829221B1 (ja) 1967-11-17 1971-07-16

Country Status (15)

Country Link
US (1) US3652554A (ja)
JP (1) JPS4829221B1 (ja)
AT (3) AT293633B (ja)
BE (1) BE723905A (ja)
BR (1) BR6804024D0 (ja)
CH (4) CH510655A (ja)
DK (1) DK129835B (ja)
FR (2) FR1594773A (ja)
GB (1) GB1245292A (ja)
MY (1) MY7400317A (ja)
NL (1) NL161767C (ja)
PL (1) PL80570B1 (ja)
SE (1) SE351634B (ja)
SU (1) SU424352A3 (ja)
YU (4) YU34138B (ja)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2010458B2 (de) * 1970-02-28 1979-04-26 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue 21-Halogensteroide
CH558787A (de) * 1970-12-10 1975-02-14 Ciba Geigy Ag Verfahren zur herstellung eines neuen halogenpregnadiens.
GB1377608A (en) * 1970-12-17 1974-12-18 Glaxo Lab Ltd 3alpha-hydroxy or acyloxy pregnene-21-ethers
NL7502252A (nl) * 1974-02-27 1975-08-29 Pierrel Spa Werkwijze voor het bereiden van een geneesmid- del met anti-inflammatoire werking, gevormd ge- neesmiddel verkregen volgens deze werkwijze alsmede werkwijze voor het bereiden van in het geneesmiddel gebruikte nieuwe steroiden.
SE418294B (sv) * 1974-03-27 1981-05-18 Plurichemie Anstalt Sett att framstella en 16alfa- eller 16beta-9alfa-klor eller -fluorsteroidester
GB1505701A (en) * 1975-06-14 1978-03-30 Pierrel Spa 2-chloro-6beta-fluoropregnanes
FR2291760A1 (fr) * 1974-11-19 1976-06-18 Pierrel Spa Nouveaux steroides a base de 2-chloro-6 b-fluoro-pregna-1,4-diene-3,20-diones
DE2655570A1 (de) * 1975-12-12 1977-06-16 Ciba Geigy Ag Neue polyhalogensteroide und verfahren zu ihrer herstellung
JP2007504123A (ja) * 2003-08-29 2007-03-01 ランバクシー ラボラトリーズ リミテッド Ｉｖ型ホスホジエステラーゼの阻害剤
US20070259874A1 (en) * 2003-11-26 2007-11-08 Palle Venkata P Phosphodiesterase Inhibitors
US7915286B2 (en) 2005-09-16 2011-03-29 Ranbaxy Laboratories Limited Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
AU2006305619A1 (en) 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Pharmaceutical compositions of muscarinic receptor antagonists
RU2008119322A (ru) * 2005-10-19 2009-11-27 Рэнбакси Лабораториз Лимитед (In) Композиции ингибиторов фосфодиэстеразы iv типа
EP2086948A2 (en) * 2006-09-22 2009-08-12 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type-iv
US20100029728A1 (en) * 2006-09-22 2010-02-04 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
EP1958947A1 (en) 2007-02-15 2008-08-20 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type 4
PL2124944T3 (pl) 2007-03-14 2012-08-31 Sun Pharmaceutical Ind Ltd Pochodne pirazolo[3,4-b]pirydyny jako inhibitory fosfodiesterazy
US20110130403A1 (en) * 2007-03-14 2011-06-02 Ranbaxy Laboratories Limited Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors
EP2111861A1 (en) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type IV inhibitors
CN102827229B (zh) * 2011-06-17 2016-01-20 重庆华邦胜凯制药有限公司 一种纯化卤米松羧酸酯的方法
CN104370987B (zh) * 2014-10-22 2016-09-14 湖南明瑞制药有限公司 一种卤米松的精制方法
CN111944004B (zh) * 2020-09-25 2023-11-17 湖南新合新生物医药有限公司 一种卤米松的制备方法

Also Published As

Publication number Publication date
FR8278M (ja) 1970-11-02
NL6816337A (ja) 1969-05-20
MY7400317A (en) 1974-12-31
BR6804024D0 (pt) 1973-01-02
DK129835B (da) 1974-11-25
YU34138B (en) 1978-12-31
DE1807980A1 (de) 1969-06-04
YU30875A (en) 1982-05-31
PL80570B1 (ja) 1975-08-30
CH510655A (de) 1971-07-31
DK129835C (ja) 1975-05-05
NL161767C (nl) 1980-03-17
YU267368A (en) 1978-06-30
AT293633B (de) 1971-10-25
AT298690B (de) 1972-04-15
DE1807980B2 (de) 1975-11-06
SE351634B (ja) 1972-12-04
YU30775A (en) 1982-05-31
CH540244A (de) 1973-08-15
US3652554A (en) 1972-03-28
SU424352A3 (ja) 1974-04-15
BE723905A (ja) 1969-05-14
CH534144A (de) 1973-02-28
YU30675A (en) 1982-05-31
AT298695B (de) 1972-05-25
CH513845A (de) 1971-10-15
FR1594773A (ja) 1970-06-08
GB1245292A (en) 1971-09-08

Similar Documents

Publication Publication Date Title
AU425114B2 (ja)
JPS4829221B1 (ja)
FR6590M (ja)
AU416737B2 (ja)
AU342066A (ja)
AU610966A (ja)
AU3151267A (ja)
AU3189468A (ja)
BE692577A (ja)
BE692375A (ja)
BE711116A (ja)
BE710547A (ja)
BE710389A (ja)
BE710057A (ja)
BE709358A (ja)
BE709208A (ja)
BE709177A (ja)
BE708764A (ja)
BE704862A (ja)
BE692780A (ja)
BE692779A (ja)
BE692778A (ja)
BE692654A (ja)
BE711128A (ja)
BE692553A (ja)